<p>(A) Expression of CD19RCD28 CAR on T cells day after electroporation (culture day 1) and after 28 days of co-culture on aAPC clone #4 along with lack of CD19<sup>+</sup> aAPC. (B) CAR expression by western blot analysis using CD3-ζ specific antibody. Whole cell lysates were run on SDS-PAGE under reducing conditions. Molecular weight marker (M), Parental Jurkat cells (Lane 1), CD19RCD28<sup>+</sup> Jurkat cells (Lane 2), CAR<sup>neg</sup> control T cells (Lane 3) and CD19RCD28<sup>+</sup> T cells (Lane 4). (C) Percent expression of CD3<sup>+</sup>, CD4<sup>+</sup>CAR<sup>+</sup> and CD8<sup>+</sup>CAR<sup>+</sup> T cells with in a lymphocyte gate in cultures over time. Each symbol represents a separate experiment; the solid lines are mean...
CD19-targeting CAR T cells have shown potency in clinical trials targeting B cell leukemia. Although...
<p>(A) Data from CRA shows inhibition of tumor cell lysis in CD19<sup>+</sup> EL4 cells when CD19-sp...
<p>(A) Anti-hPSMA CAR map. EC: extracellular domain; TM: transmembrane domain; IC: intracellular dom...
<p>Genetically modified T cells were co-cultured with aAPC clone #4 for 28 days. At the end of each ...
<p>(A) CAR<sup>+</sup> T cells were electroporated with <i>Sleeping Beauty</i> system and propagated...
<p>(A) Plots represent CAR transduction efficiencies in primary T cells, measured by flow cytometry ...
<p>Lineage (A; CD3+ CD8+), exhaustion phenotype (B; PD-1+ Tim-3+) and memory/effector status (C) wer...
<p>(<b>A</b>) Flow cytometric examination of surface expression of the CD20-CAR and CD19. Mock, non-...
<p>CAR expression on 2G (A, B) and 3G (C, D) T cells was evaluated by flow cytometry before and afte...
<p>After 29 days of expansion on clone#1 AaPC/IL-2/IL-21, ROR1RCD28 and ROR1RCD137 cells were (i) ly...
<p>(<b>a</b>) Expression of CARs (αerbB2-CD28ζ: 57.99±12.66, αerbB2-DAP10ζCD27: 66.38±22.90. N = 3± ...
T cells engineered to express chimeric antigen receptors (CARs) targeting CD19 have produced impress...
Chimeric-antigen-receptor-T (CAR-T) cells are currently revolutionizing the field of cancer immunoth...
<p>(A)Short-term culture. G3 CAR T-cells were co-cultured with three different aAPCs as shown. (B)G1...
<p>A MCB (PACT) and WCB (MDACC) were generated for K562-derived aAPC (clone #4). For the generation ...
CD19-targeting CAR T cells have shown potency in clinical trials targeting B cell leukemia. Although...
<p>(A) Data from CRA shows inhibition of tumor cell lysis in CD19<sup>+</sup> EL4 cells when CD19-sp...
<p>(A) Anti-hPSMA CAR map. EC: extracellular domain; TM: transmembrane domain; IC: intracellular dom...
<p>Genetically modified T cells were co-cultured with aAPC clone #4 for 28 days. At the end of each ...
<p>(A) CAR<sup>+</sup> T cells were electroporated with <i>Sleeping Beauty</i> system and propagated...
<p>(A) Plots represent CAR transduction efficiencies in primary T cells, measured by flow cytometry ...
<p>Lineage (A; CD3+ CD8+), exhaustion phenotype (B; PD-1+ Tim-3+) and memory/effector status (C) wer...
<p>(<b>A</b>) Flow cytometric examination of surface expression of the CD20-CAR and CD19. Mock, non-...
<p>CAR expression on 2G (A, B) and 3G (C, D) T cells was evaluated by flow cytometry before and afte...
<p>After 29 days of expansion on clone#1 AaPC/IL-2/IL-21, ROR1RCD28 and ROR1RCD137 cells were (i) ly...
<p>(<b>a</b>) Expression of CARs (αerbB2-CD28ζ: 57.99±12.66, αerbB2-DAP10ζCD27: 66.38±22.90. N = 3± ...
T cells engineered to express chimeric antigen receptors (CARs) targeting CD19 have produced impress...
Chimeric-antigen-receptor-T (CAR-T) cells are currently revolutionizing the field of cancer immunoth...
<p>(A)Short-term culture. G3 CAR T-cells were co-cultured with three different aAPCs as shown. (B)G1...
<p>A MCB (PACT) and WCB (MDACC) were generated for K562-derived aAPC (clone #4). For the generation ...
CD19-targeting CAR T cells have shown potency in clinical trials targeting B cell leukemia. Although...
<p>(A) Data from CRA shows inhibition of tumor cell lysis in CD19<sup>+</sup> EL4 cells when CD19-sp...
<p>(A) Anti-hPSMA CAR map. EC: extracellular domain; TM: transmembrane domain; IC: intracellular dom...